Literature DB >> 5274461

Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity.

L J Strand, B F Felsher, A G Redeker, H S Marver.   

Abstract

Hepatic conversion of porphobilinogen to porphyrins was less than 50% of control levels in human subjects with the genetic disease, intermittent acute porphyria. This relative block in heme biosynthesis may be relevant to a concomitant 6- to 10-fold elevation in delta-aminolevulinic acid synthetase activity, since this first and rate-controlling enzyme in the biosynthetic pathway is subject to negative feedback regulation by the end product, heme. A micro-radio-chemical assay of delta-aminolevulinic acid synthetase, and some of its applications, are described.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5274461      PMCID: PMC283354          DOI: 10.1073/pnas.67.3.1315

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  A simple micro method for the direct determination of delta-amino (14C) levulinic acid production in murine spleen and liver homogenates.

Authors:  P S Ebert; D P Tschudy; J N Choudhry; M A Chirigos
Journal:  Biochim Biophys Acta       Date:  1970-05-12

2.  Mechanism of allylisopropylacetamide-induced increase of delta-aminolevulinate synthetase in liver mitochondria. II. Effects of hemin and bilirubin on enzyme induction.

Authors:  N Hayashi; B Yoda; G Kikuchi
Journal:  J Biochem       Date:  1968-04       Impact factor: 3.387

Review 3.  [Biochemical pathogenesis of acute intermittent porphyria].

Authors:  L Heilmeyer; R Clotten
Journal:  Klin Wochenschr       Date:  1969-01-15

Review 4.  Acute intermittent porphyria. A clinical and biochemical study of 46 patients.

Authors:  J A Stein; D P Tschudy
Journal:  Medicine (Baltimore)       Date:  1970-01       Impact factor: 1.889

5.  The metabolism of (5-14C)delta-aminolaevulic acid in normal and porphyric human subjects.

Authors:  E Dowdle; P Mustard; N Spong; L Eales
Journal:  Clin Sci       Date:  1968-04       Impact factor: 6.124

6.  The porphyrias: a genetic problem.

Authors:  J Waldenström; B Haeger-Aronsen
Journal:  Prog Med Genet       Date:  1967

7.  A sensitive radiochemical assay method for delta-aminolevulinic acid synthetase.

Authors:  E A Irving; W H Elliott
Journal:  J Biol Chem       Date:  1969-01-10       Impact factor: 5.157

8.  Activity of amino-laevulinic acid synthetase in normal and porphyric human livers.

Authors:  K Nakao; O Wada; T Kitamura; K Uono; G Urata
Journal:  Nature       Date:  1966-05-21       Impact factor: 49.962

9.  The induction in vitro of the synthesis of delta-aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs, sex hormones, and foreign chemicals.

Authors:  S Granick
Journal:  J Biol Chem       Date:  1966-03-25       Impact factor: 5.157

10.  Mutant strains of Rhodopseudomonas spheroides lacking delta-aminolevulinate synthase: growth, heme, and bacteriochlorophyll synthesis.

Authors:  J Lascelles; T Altschuler
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

View more
  50 in total

1.  Marked geographic aggregation of acute intermittent porphyria families carrying mutation Q180X in Venezuelan populations, with description of further mutations.

Authors:  Irene Paradisi; Sergio Arias
Journal:  J Inherit Metab Dis       Date:  2010-10-27       Impact factor: 4.982

2.  Acute intermittent porphyria: identification and expression of exonic mutations in the hydroxymethylbilane synthase gene. An initiation codon missense mutation in the housekeeping transcript causes "variant acute intermittent porphyria" with normal expression of the erythroid-specific enzyme.

Authors:  C H Chen; K H Astrin; G Lee; K E Anderson; R J Desnick
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

Review 3.  Porphobilinogen deaminase gene structure and molecular defects.

Authors:  J C Deybach; H Puy
Journal:  J Bioenerg Biomembr       Date:  1995-04       Impact factor: 2.945

4.  Characterization of the porphobilinogen deaminase deficiency in acute intermittent porphyria. Immunologic evidence for heterogeneity of the genetic defect.

Authors:  P M Anderson; R M Reddy; K E Anderson; R J Desnick
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

Review 5.  Inborn errors of metabolism: clues to understanding human behavioral disorders.

Authors:  G S Omenn
Journal:  Behav Genet       Date:  1976-07       Impact factor: 2.805

6.  Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes.

Authors:  S Sassa; G L Zalar; A Kappas
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

7.  Factors determining the sequence of oxidative decarboxylation of the 2- and 4-propionate substituents of coproporphyrinogen III by coproporphyrinogen oxidase in rat liver.

Authors:  G H Elder; J O Evans; J R Jackson; A H Jackson
Journal:  Biochem J       Date:  1978-01-01       Impact factor: 3.857

8.  Decreased red cell uroporphyrinogen I synthetase activity in intermittent acute porphyria.

Authors:  L J Strand; U A Meyer; B F Felsher; A G Redeker; H S Marver
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

9.  An autopsy case of acute porphyria with a decrease of both uroporphyrinogen I synthetase and ferrochelatase activities.

Authors:  M Yamada; M Kondo; M Tanaka; R Okeda; S Hatakeyama; T Fukui; H Tsukagoshi
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

10.  delta-Aminolevulinic acid effects on neuronal and glial tumor cell lines.

Authors:  L Helson; S Braverman; J Mangiardi
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.